Cervical Cancer News and Research

RSS

Cancer is a disease in which cells in the body grow out of control. Cancer is always named for the part of the body where it starts, even if it spreads to other body parts later. When cancer starts in the cervix, it is called cervical cancer. The cervix is the lower, narrow end of the uterus. Also known as the womb, the uterus is where a baby grows when a woman is pregnant. The cervix connects the upper part of the uterus to the vagina (birth canal).

Cervical cancer is highly preventable in most Western countries because screening tests and a vaccine to prevent HPV infections are available. When cervical cancer is found early, it is highly treatable and associated with long survival and good quality of life.

COVID-19-related disruptions to cervical cancer screening could increase risk sevenfold, UK case study finds

A new study reveals inequalities in the delay in screening for cervical cancer, and recommends that the screening capacity be increased in addition to giving a higher priority to women who have missed their scheduled visit.

2 Dec 2020

Innovative radiotherapy technique benefits patients with locally advanced cervical cancer

Patients with locally advanced cervical cancer benefit significantly from an innovative radiotherapy technique co-developed by MedUni Vienna under the direction of Richard Pötter and Christian Kirisits. The technique provides better tumor control and produces fewer side-effects.

26 Nov 2020

Paris illuminates in teal for cervical cancer elimination

Paris, the City of Lights, celebrated the world's historic commitment to eliminate cervical cancer by illuminating in teal on November 17th. Standing in solidarity with over 100 landmarks across the globe, Town Hall glimmered like a beacon of hope for a cervical cancer-free future.

24 Nov 2020

Multi-faceted COVID-19 strategy can prevent infections, save lives in resource-challenged countries

A public health strategy that combines contact tracing and community-based screening with isolation and quarantine centers can substantially reduce infections, hospitalizations and deaths from COVID-19 while being cost-effective in low-and-middle-income countries like South Africa, a study by Massachusetts General Hospital has found.

15 Nov 2020

Study shows potential of new pinprick blood test for diagnosing HPV-related cancers

A potential breakthrough in the early detection of the neck, head and anal cancers linked to human papilloma viruses has emerged.

12 Nov 2020

World Health Assembly to discuss plan for addressing COVID-19 response and critical health goals

As health leaders prepare to gather for a virtual session of the resumed 73rd World Health Assembly (WHA), WHO has three messages to share.

5 Nov 2020

HPV vaccination mandates did not improve rates of HPV vaccine series completion, shows study

A postdoctoral researcher at the University of California, Riverside, has discovered human papillomavirus, or HPV, vaccination mandates fall short of ensuring both higher levels of uptake and equal uptake of the vaccine across socioeconomic and racial-ethnic groups.

6 Oct 2020

Two phase II clinical trials suggest potential new treatment options for metastatic cervical cancer

Preliminary results from two independent, phase II clinical trials investigating a new PD-1 (programmed cell death protein 1)-based immune therapy for metastatic cervical cancer suggest potential new treatment options for a disease that currently has limited effective options and disproportionately impacts younger women.

5 Oct 2020

Valproic acid can interact with DNA conformation and regulate gene expression

Results of recent studies involving valproic acid, used for decades as an anti-convulsant drug, show that it can interact with the conformation of DNA and regulate gene expression.

29 Sep 2020

Research consortium receives $111 million NCI grant to prevent, treat HIV-related cancers

The widespread use of antiretroviral therapy to suppress the HIV virus has helped tens of millions of people with HIV live healthier, longer lives--but an unfortunate consequence of people living longer with HIV is an increased risk of cancer.

22 Sep 2020

NAU researcher awarded $3.75 million NCI grant to build cancer research software

Greg Caporaso, director of the Center for Applied Microbiome Science, part of the Pathogen and Microbiome Institute at Northern Arizona University, has been awarded a $3.75 million grant by the National Cancer Institute to build software capable of analyzing and archiving data focused on the interplay between the human microbiome (the trillions of microorganisms living in and on the human body) and diverse types of cancer.

22 Sep 2020

Smartphones could be used to detect Type 2 diabetes

Researchers at UC San Francisco have developed a "digital biomarker" that would use a smartphone's built-in camera to detect Type 2 diabetes - one of the world's top causes of disease and death - potentially providing a low-cost, in-home alternative to blood draws and clinic-based screening tools.

17 Aug 2020

HPV type may impact cervical cancer characteristics and prognosis

An analysis of cervical cancers in Ugandan women has uncovered significant genomic differences between tumors caused by different strains of human papillomavirus (HPV), signifying HPV type may impact cervical cancer characteristics and prognosis.

10 Aug 2020

Tasmanian devil research provides new insights for treating human cancers in future

A rare, transmissible tumor has brought the iconic Tasmanian devil to the brink of extinction, but new research by scientists at Washington State University and the Fred Hutchinson Cancer Research Center in Seattle indicates hope for the animals' survival and possibly new treatment for human cancers.

6 Aug 2020

HPV vaccination reduces risk of cervical cancer

Vaccination against the human papilloma virus (HPV) reduces the risk of a condition that often leads to cervical cancer, according to an analysis of Danish health registry data.

5 Aug 2020

Research assesses the prevalence of overscreening for cancers among older adults

Older Americans may be receiving cancer screenings not recommended by the U.S. Preventive Services Task Force, according to Penn State College of Medicine researchers.

30 Jul 2020

Updated cervical cancer screening guideline calls for less and more simplified screening

An updated cervical cancer screening guideline from the American Cancer Society reflects the rapidly changing landscape of cervical cancer prevention in the United States, calling for less and more simplified screening. The guideline appears in the ACS's flagship journal, CA: A Cancer Journal for Clinicians.

30 Jul 2020

New cancer imaging system hastens cancer detection

A new study highlights a novel imaging system that utilizes near-infrared light, which makes the procedure less invasive and produces faster results.

24 Jul 2020

Novel imaging system can diagnose cancer more efficiently than conventional methods

Cancer diagnosis requires a lengthy process of multiple analyses of tissue biopsies, impeding the quick and early detection of cancers.

23 Jul 2020

Quest Diagnostics Health Trends study: HPV screening less likely to detect cervical cancer than cotesting

A Health Trends study from researchers at Quest Diagnostics and the University of Pittsburgh Medical Center provides new evidence that the HPV screening test is significantly less likely to detect cervical cancer and precancer than cotesting, a method which combines HPV and Pap testing using the same specimen.

15 Jul 2020